Adaptive Biotechnologies' Series D Round

Adaptive Biotechnologies raised a round of funding on April 07, 2014. Investors include Viking Global Investors.

Adaptive Biotechnologies, formerly Adaptive TCR, is a pioneer in immunosequencing diagnostics, with a focus in oncology. The Company leverages advances in next generation sequencing ("NGS") to profile…

Articles about Adaptive Biotechnologies' Series D Round: